Non-Interventional Study to Examine Rituximab Treatment in Follicular Lymphoma Participants

NCT02536664 · clinicaltrials.gov ↗

COMPLETED

Status

505

Enrollment

INDUSTRY

Sponsor class

Conditions

Follicular Lymphoma

Interventions

DRUG: Rituximab

Sponsor

Hoffmann-La Roche